GLP-1 receptor agonists, offering clinically proven and durable weight-loss outcomes, are thus positioned to capture expanding demand in obesity management, driving market growth globally and complementing their use in diabetes care
Inpatient, outpatient and partial hospitalization rehabilitation programs all offer enough of a reprieve from lifes stressors to make addiction recovery more attainable
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
The integration of these tools requires individualized clinical assessment rather than a one-size-fits-all protocol, which is the defining characteristic of a serious longevity medicine practice
ADAP Advocacy and the Partnership for Safe Medicines (PSM) issued the following joint statement as a warning to pharmacists that all discounted HIV products bought from online, pharmacy-to-pharmacy (P2P) marketplaces fit the definition of suspect product under U.S
